<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE root>
<article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:ali="http://www.niso.org/schemas/ali/1.0/" article-type="other" dtd-version="1.2" xml:lang="en"><front><journal-meta><journal-id journal-id-type="publisher-id">Terapevticheskii arkhiv</journal-id><journal-title-group><journal-title xml:lang="en">Terapevticheskii arkhiv</journal-title><trans-title-group xml:lang="ru"><trans-title>Терапевтический архив</trans-title></trans-title-group></journal-title-group><issn publication-format="print">0040-3660</issn><issn publication-format="electronic">2309-5342</issn><publisher><publisher-name xml:lang="en">LLC Obyedinennaya Redaktsiya</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="publisher-id">30601</article-id><article-categories><subj-group subj-group-type="toc-heading" xml:lang="en"><subject>Editorial article</subject></subj-group><subj-group subj-group-type="toc-heading" xml:lang="ru"><subject>Передовая статья</subject></subj-group><subj-group subj-group-type="article-type"><subject></subject></subj-group></article-categories><title-group><article-title xml:lang="en">Community-acquired pneumonia in adults: Approaches to antibacterial therapy in the context of current clinical guidelines</article-title><trans-title-group xml:lang="ru"><trans-title>Внебольничная пневмония у взрослых: подходы к антибактериальной терапии с позиции современных клинических рекомендаций</trans-title></trans-title-group></title-group><contrib-group><contrib contrib-type="author"><name-alternatives><name xml:lang="en"><surname>Sinopalnikov</surname><given-names>A I</given-names></name><name xml:lang="ru"><surname>Синопальников</surname><given-names>Александр Игоревич</given-names></name></name-alternatives><bio xml:lang="en"><p>State Institute for Qualification Improvement of Physicians, Ministry of Defense of the Russian Federation, Moscow</p></bio><bio xml:lang="ru"><p>д-р мед. наук, проф., акад. РАЕН, зав. каф. пульмонологии; Государственный институт усовершенствования врачей МО РФ</p></bio><email>aisyn@list.ru</email><xref ref-type="aff" rid="aff1"/></contrib></contrib-group><aff-alternatives id="aff1"><aff><institution xml:lang="en">State Institute for Qualification Improvement of Physicians, Ministry of Defense of the Russian Federation, Moscow</institution></aff><aff><institution xml:lang="ru">Государственный институт усовершенствования врачей МО РФ</institution></aff></aff-alternatives><pub-date date-type="pub" iso-8601-date="2010-08-15" publication-format="electronic"><day>15</day><month>08</month><year>2010</year></pub-date><volume>82</volume><issue>8</issue><issue-title xml:lang="en">NO8 (2010)</issue-title><issue-title xml:lang="ru">ТОМ 82, №8 (2010)</issue-title><fpage>5</fpage><lpage>10</lpage><history><date date-type="received" iso-8601-date="2020-04-09"><day>09</day><month>04</month><year>2020</year></date></history><permissions><copyright-statement xml:lang="en">Copyright ©; 2010, Consilium Medicum</copyright-statement><copyright-statement xml:lang="ru">Copyright ©; 2010, ООО "Консилиум Медикум"</copyright-statement><copyright-year>2010</copyright-year><copyright-holder xml:lang="en">Consilium Medicum</copyright-holder><copyright-holder xml:lang="ru">ООО "Консилиум Медикум"</copyright-holder><ali:free_to_read xmlns:ali="http://www.niso.org/schemas/ali/1.0/"/><license><ali:license_ref xmlns:ali="http://www.niso.org/schemas/ali/1.0/">https://creativecommons.org/licenses/by-nc-sa/4.0</ali:license_ref></license></permissions><self-uri xlink:href="https://ter-arkhiv.ru/0040-3660/article/view/30601">https://ter-arkhiv.ru/0040-3660/article/view/30601</self-uri><abstract xml:lang="en"><p>Conciliatory guidelines for management of patients with either disease/abnormality have recently become an integral part of medical practice. The popularity of the guidelines is likely to owe to the fact that they are a more or less successful synthesis of abundant information within one document, by giving a physician detailed many-year and many-decade clinical and scientific experience. Since their publication, they become a peculiar standard of medical care delivery. The main benefit of such guidelines should be seen in the diagnosis and treatment standardization (without a physician's losing his/her reasonable autonomy in each individual case) that makes it possible to optimize a diagnostic process, to apply more effective therapeutic approaches, and to use less health care resources.
By taking into account the drastically changing epidemiology of resistance of the causative agents of respiratory tract infection, the emergence of new antibiotics, and the rethinking of conventional diagnostic and therapeutic approaches, there is an apparent need for periodic revision and modification of such guidelines. In this regard, of particular interest are the conciliatory guidelines of the Russian Respiratory Society and Interregional Association of Clinical Microbiology and Antimicrobial Chemotherapy, which were published in 2010.</p></abstract><trans-abstract xml:lang="ru"><p>В последнее время неотъемлемой частью медицинской практики становятся согласительные рекомендации по ведению больных с тем или иным заболеванием/патологическим состоянием. Очевидно, что популярность рекомендаций объясняется тем, что они представляют собой более или менее удачный синтез огромного объема информации в рамках одного документа, предоставляя врачу детальный, накопленный годами и десятилетиями клинический и научный опыт. С момента опубликования они становятся своеобразным стандартом оказания медицинской помощи. В стандартизации диагностики и лечения (без утраты врачом разумной автономии в каждом отдельном случае заболевания), позволяющей оптимизировать диагностический процесс, использовать более эффективные лечебные подходы и более экономно расходовать ресурсы здравоохранения, следует видеть основную выгоду подобных рекомендаций.
С учетом стремительно меняющейся эпидемиологии резистентности возбудителей инфекций дыхательных путей, появления новых антибиотиков, переосмысления привычных диагностических и лечебных подходов очевидна необходимость в периодическим пересмотре и модификации подобных рекомендаций. В этом смысле особый интерес представляют вышедшие в свет согласительные рекомендации Российского респираторного общества и Межрегиональной ассоциации по клинической микробиологии и антимикробной химиотерапии (2010 г.).</p></trans-abstract><kwd-group xml:lang="en"><kwd>community-acquired pneumonia</kwd><kwd>antibacterial therapy</kwd><kwd>clinical guidelines</kwd></kwd-group><kwd-group xml:lang="ru"><kwd>внебольничная пневмония</kwd><kwd>антибактериальная терапия</kwd><kwd>клинические рекомендации</kwd></kwd-group></article-meta></front><body></body><back><ref-list><ref id="B1"><label>1.</label><mixed-citation>Чучалин А. Г., Синопальников А. И., Страчунский Л. С. и др. Внебольничная пневмония у взрослых. Практические рекомендации по диагностике, лечению и профилактике. М.: OOO "Изд. дом "М-Вести", 2006.</mixed-citation></ref><ref id="B2"><label>2.</label><mixed-citation>Mandell L. A., Niederman M. S. Antimicrobial treatment of community-acquired pneumonia in adults: a conference report. Canadian Community-Acquired Pneumonia Consensus Conference Group. Can. J. Infect. Dis. 1993; 4: 25-51.</mixed-citation></ref><ref id="B3"><label>3.</label><mixed-citation>Niederman M. S., Bass J. B., Campbell G. D. et al. Guidelines for the initial empiric therapy of community-acquired pneumonia: proceedings of an American Thoracic Society Consensus Conference. Am. Rev. Resp. Dis. 1993; 148: 1418-1426.</mixed-citation></ref><ref id="B4"><label>4.</label><mixed-citation>Charles P. G. P. Development of a severity assessment tool for predicting need for ICU admission in patients with community-acquired pneumonia (CAP). In: 46th ICAAC. San Francisco, 2006.</mixed-citation></ref><ref id="B5"><label>5.</label><mixed-citation>Charles P. G. P., Fine M. J., Ramirez J. A. et al. Validation of SMART-COP: a pneumoniae severity assessment tool for predicting with patients will need intensive respiratory or inotropic support (IRIS). In: 47th ICAAC, Chicago; 2007. Abstr. L1156a.</mixed-citation></ref><ref id="B6"><label>6.</label><mixed-citation>Mandell L. A., Wunderink R. G., Antonio A. et al. Infectious Diseases Society of America/ American Thoracic Society Consensus Guidelines on the management of community-acquired pneumonia in adults. Clin. Infect. Dis. 2007; 44 (Suppl. 2): S27-S72.</mixed-citation></ref><ref id="B7"><label>7.</label><mixed-citation>Lim W. S., Baudouin S. V., George R. C. et al. British Thoracic Society guidelines for the management of community acquired pneumonia in adults: update 2009. Thorax 2009; 64 (Suppl. III): iii1-iii55.</mixed-citation></ref><ref id="B8"><label>8.</label><mixed-citation>File T. M. Optimal treatment strategies for community-acquired pneumonia: non-responders to conventional regimens. Chemotherapy 2001; 47 (Suppl. 4): 11-18.</mixed-citation></ref><ref id="B9"><label>9.</label><mixed-citation>Fine M. J., Auble T. E., Yealy D. M. et al. A prediction rule to identify low-risk patients with community-acquired pneumonia. N. Engl. J. Med. 1997; 336: 243-257.</mixed-citation></ref><ref id="B10"><label>10.</label><mixed-citation>Ruiz-Gonz?lez A., Falguera M., Nogués A., Rubio-Caballero M. Is Streptococcus pneumoniae the leading cause of pneumonia of unknown etiology? A microbiologic study of lung aspirates in consecutive patients with community-acquired pneumonia. Am. J. Med. 1999; 106: 385-390.</mixed-citation></ref><ref id="B11"><label>11.</label><mixed-citation>Bjerre L. M., Verheij T. J., Kochen M. M. Antibiotics for community acquired pneumonia in adult outpatients. Cochrane Database Syst. Rev. 2009; 4: CD002109.</mixed-citation></ref><ref id="B12"><label>12.</label><mixed-citation>Meehan T. P., Fine M. J., Krumholz H. M. et al. Quality of care, process, and outcomes in elderly patients with pneumonia. J. A. M. A. 1997; 278: 2080-2084.</mixed-citation></ref><ref id="B13"><label>13.</label><mixed-citation>Houck P. M., Bratzler D. W., Nsa W. et al. Timing of antibiotic administration and outcomes for medicare patients hospitalized with community-acquired pneumonia. Arch. Intern. Med. 2004; 164: 637-644.</mixed-citation></ref><ref id="B14"><label>14.</label><mixed-citation>Dunbar L. M., Wunderink R. G., Habib M. P. et al. High-dose, short-course levofloxacin for community- acquired pneumonia: a new treatment paradigm. Clin. Infect. Dis. 2003; 37: 752-760.</mixed-citation></ref><ref id="B15"><label>15.</label><mixed-citation>Ramirez J. A., Srinath L., Ahkee S. et al. Early switch from intravenous to oral cephalosporins in the treatment of hospitalized patients with community-acquired pneumonia. Arch. Intern. Med. 1995; 155: 1273-1276.</mixed-citation></ref><ref id="B16"><label>16.</label><mixed-citation>Halm E. A., Fine M. J., Marrie T. J. et al. Time to clinical stability in patients hospitalized with community-acquired pneumonia: implications for practice guidelines. J. A. M. A. 1998; 279: 1452-1457.</mixed-citation></ref><ref id="B17"><label>17.</label><mixed-citation>Menendez R., Torres A., Rodr?guez de Castro F. et al. Reaching stability in community-acquired pneumonia: the effects of the severity of disease, treatment, and the characteristics of patients. Clin. Infect. Dis. 2004; 39: 1783-1790.</mixed-citation></ref><ref id="B18"><label>18.</label><mixed-citation>Niederman M. S., Mandell L. A., Anzueto A. et al. Guidelines for the management of adults with community-acquired pneumonia. Diagnosis, assessment of severity, antimicrobial therapy, and prevention. Am. J. Respir. Crit. Care. Med 2001; 163: 1730-1754.</mixed-citation></ref></ref-list></back></article>
